Bicycle Therapeutics

NASDAQ: BCYC · Real-Time Price · USD
7.66
-0.38 (-4.73%)
At close: Jun 17, 2025, 3:59 PM

Bicycle Therapeutics Statistics

Share Statistics

Bicycle Therapeutics has 69.2M shares outstanding. The number of shares has increased by 61.99% in one year.

69.2M
61.99%
0.07%
60.72%
61.47M
9,773
2.77%

Short Selling Information

The latest short interest is 3.45M, so 4.98% of the outstanding shares have been sold short.

3.45M
4.98%
9.5%
14.16

Valuation Ratios

The PE ratio is -48.21 and the forward PE ratio is -1.89. Bicycle Therapeutics's PEG ratio is 0.51.

-48.21
-1.89
231.02
0.9
10.28
-49.1
0.51
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Bicycle Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 13.81, with a Debt / Equity ratio of 0.01.

13.81
13.81
0.01
-0.06
-0.06
-121.31

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$115,655.74
$-554,200
305
0.04
n/a

Taxes

-4.76M
2.74%

Stock Price Statistics

The stock price has increased by -63.62% in the last 52 weeks. The beta is 1.47, so Bicycle Therapeutics's price volatility has been higher than the market average.

1.47
-63.62%
8.1
15.27
43.92
352,450

Income Statement

In the last 12 months, Bicycle Therapeutics had revenue of 35.27M and earned -169.03M in profits. Earnings per share was -0.29.

35.27M
28.11M
-209.87M
-169.03M
-164.89M
-172.07M
-0.29
Full Income Statement

Balance Sheet

The company has 879.52M in cash and 9.49M in debt, giving a net cash position of 870.03M.

879.52M
9.49M
870.03M
-680.79M
883.89M
798.46M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -164.72M and capital expenditures -1.24M, giving a free cash flow of -165.96M.

-164.72M
-1.24M
-165.96M
-0.29
Full Cash Flow Statement

Margins

Gross margin is 79.7%, with operating and profit margins of -594.96% and -479.18%.

79.7%
-594.96%
-492.69%
-479.18%
-467.45%
-594.96%
-470.47%

Dividends & Yields

BCYC does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for BCYC is $24, which is 198.5% higher than the current price. The consensus rating is "Buy".

$24
198.5%
Buy
11
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

1.5
4